GSA CAPITAL PARTNERS LLP - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2021$170,000
+448.4%
74,790
+338.7%
0.03%
+460.0%
Q4 2020$31,000
-85.0%
17,047
-82.2%
0.01%
-85.3%
Q3 2020$206,00095,7540.03%
Other shareholders
AIM IMMUNOTECH INC shareholders Q3 2020
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,873$26,0000.12%
GSA CAPITAL PARTNERS LLP 95,754$206,0000.03%
Arkadios Wealth Advisors 20,000$45,400,0000.02%
Bayesian Capital Management, LP 42,200$91,0000.02%
SeaCrest Wealth Management, LLC 50,515$109,0000.02%
Virtu Financial LLC 29,604$64,0000.01%
Traynor Capital Management, Inc. 14,777$31,0000.01%
WEDBUSH SECURITIES INC 13,295$29,0000.00%
Verition Fund Management LLC 40,000$86,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 11,600$25,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders